United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - dopamine hydrochloride - solution for infusion - 40mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - dopamine hydrochloride - solution for infusion - 160mg/1ml

United States - English - NLM (National Library of Medicine)

professional complementary health formulas - dopamine 9x, 12x, 30x, 60x - for the temporary relief of occasional headache, anxiousness, forgetfulness, hay fever, or congestion due to sensitivity to phenolic compounds found in foods or other products.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Ireland - English - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals (ireland) ltd - dopamine hydrochloride - concentrate for solution for infusion - 40 milligram(s)/millilitre - adrenergic and dopaminergic agents; dopamine

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - dopamine hydrochloride (unii: 7l3e358n9l) (dopamine - unii:vtd58h1z2x), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - dopamine hydrochloride 80 mg in 100 ml - dopamine hydrochloride in 5% dextrose injection usp is indicated for the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarctions, trauma, endotoxic septicemia, open heart surgery, renal failure, and chronic cardiac decompensation as in congestive heart failure. where appropriate, restoration of blood volume with a suitable plasma expander or whole blood should be instituted or completed prior to administration of dopamine. patients most likely to respond adequately to administration of dopamine are those in whom physiological parameters such as urine flow, myocardial function, and blood pressure, have not undergone profound deterioration. multiclinic trials indicate that the shorter the time interval between onset of signs and symptoms and initiation of therapy with volume correction and dopamine, the better the prognosis. poor perfusion of vital organs - urine flow appears to be one of the diagnostic signs by which adequacy of vital organ perfusion can be monitored.

Canada - English - Health Canada

baxter corporation - dopamine hydrochloride; dextrose - solution - 3.2mg; 50mg - dopamine hydrochloride 3.2mg; dextrose 50mg - selective beta 1-adrenergic agonists

Canada - English - Health Canada

baxter corporation - dopamine hydrochloride; dextrose - solution - 1.6mg; 50mg - dopamine hydrochloride 1.6mg; dextrose 50mg - selective beta 1-adrenergic agonists

Canada - English - Health Canada

baxter corporation - dopamine hydrochloride; dextrose - solution - 0.8mg; 50mg - dopamine hydrochloride 0.8mg; dextrose 50mg - selective beta 1-adrenergic agonists

Canada - English - Health Canada

hospira healthcare ulc - dopamine hydrochloride; dextrose - solution - 1.6mg; 50mg - dopamine hydrochloride 1.6mg; dextrose 50mg - selective beta 1-adrenergic agonists

Canada - English - Health Canada

hospira healthcare ulc - dopamine hydrochloride; dextrose - solution - 0.8mg; 50mg - dopamine hydrochloride 0.8mg; dextrose 50mg - selective beta 1-adrenergic agonists